{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"0","value":"0"},{"groupId":"OG001","lowerLimit":"46.7","upperLimit":"95.1","value":"66.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"92"},{"groupId":"OG001","value":"51"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1272.5","upperLimit":"1853.1","value":"1535.6"},{"groupId":"OG001","lowerLimit":"2249.0","upperLimit":"3863.6","value":"2947.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"45"}],"units":"Participants"}],"title":"Month 7"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"352.5","upperLimit":"578.5","value":"451.6"},{"groupId":"OG001","lowerLimit":"1095.2","upperLimit":"1884.6","value":"1436.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"title":"Month 12"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"237.6","upperLimit":"403.1","value":"309.5"},{"groupId":"OG001","lowerLimit":"892.2","upperLimit":"1731.5","value":"1242.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"title":"Month 18"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"195.5","upperLimit":"379.6","value":"272.4"},{"groupId":"OG001","lowerLimit":"771.8","upperLimit":"1510.0","value":"1079.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"37"}],"units":"Participants"}],"title":"Month 24"}],"denoms":[{"counts":[{"groupId":"OG000","value":"92"},{"groupId":"OG001","value":"51"}],"units":"Participants"}],"description":"Geometric mean concentration of antibodies for HPV 16 at each visit","dispersionType":"95% Confidence Interval","groups":[{"description":"Sero-negative for HPV 16 at baseline.","id":"OG000","title":"HPV 16 Sero-negative at Baseline"},{"description":"Sero-positive for HPV 16 at baseline","id":"OG001","title":"HPV 16 Sero-positive at Baseline"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Eligible participants who received at least one vaccination with evaluable serum assessments.","reportingStatus":"POSTED","timeFrame":"Baseline through 24 months","title":"Geometric Mean Titers for HPV 16","type":"SECONDARY","unitOfMeasure":"mMU/mL"}